Effective January 1, 2017, payment for infusion drugs furnished through a covered item of DME will be based on Section 1847A of the Social Security Act, meaning that most of the payments will be based on the Average Sales Price of these drugs. The ASP Drug Pricing data for 2017 and subsequent years will no longer contain values for the Infusion AWP or the DME infusion limit. Unless otherwise specified, the Payment Limit will be applied to payments for drugs infused through covered DME. Additional information of DME Infusion Drug Pricing is available through the DME MACs.
Medicare Part B Drug Average Sales Price & Payment Allowance Limits
Effective April 1, 2021 - June 30, 2021
Effective January 1, 2021 through March 31, 2021
Effective October 1, 2020 through December 31, 2020
Effective July 1, 2020 through September 30, 2020
Effective April 1, 2020 through June 30, 2020
Effective April 1, 2021 - June 30, 2021
Effective January 1, 2021 through March 31, 2021
Effective October 1, 2020 through December 31, 2020
Effective July 1, 2020 through September 30, 2020
Effective April 1, 2020 through June 30, 2020